Viread 245 mg film-coated tablets
Sponsors
Karolinska University Hospital, Antwerp University Hospital, Vir Biotechnology Inc., Stichting Radboud universitair medisch centrum, ANRS Maladies Infectieuses Emergentes
Conditions
Chronic Hepatitis B Virus (HBV) InfectionChronic hepatitis B infectionHBVHIV-infectedHepatitis B Infectionhepatitis D
Phase 2
ANRS HB07 IP-Cure-B proof of concept (PoC) clinical trial. Educating the liver immune environment through TLR8 stimulation followed by NUC discontinuation.
Active, not recruitingCTIS2024-515739-32-00
Start: 2022-01-10Target: 51Updated: 2025-12-31
A Platform Study Evaluating the Efficacy and Safety of Investigational Therapies in Participants with Chronic Hepatitis B Infection (PREVAIL)
CompletedCTIS2024-513176-17-00
Start: 2023-03-30End: 2025-08-19Target: 13Updated: 2025-09-03
Controlled Interruption of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Infections
Active, not recruitingCTIS2024-511016-25-00
Start: 2025-01-15Target: 140Updated: 2025-01-15
Phase 3
Observational Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Patients with Chronic hepatitis D
RecruitingCTIS2023-504414-29-00
Start: 2023-06-19Target: 400Updated: 2023-05-12
A Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Patients with Chronic Hepatitis B Infection
CompletedCTIS2024-517526-26-00
Start: 2012-12-06End: 2025-06-05Target: 23Updated: 2024-11-07